Murine lymphokine-activated killer (LAK) cells; phenotypic characterization of the precursor and effector cells

J. C. Yang, J. J. Mule, S. A. Rosenberg

Research output: Contribution to journalArticle

Abstract

Murine and human lymphocytes incubated in recombinant interleukin 2 (RIL 2) generate a population of cytotoxic cells (lymphokine-activated killer cells [LAK]), which are able to lyse a wide array of fresh tumor cells but do not lyse fresh normal cells. Intravenous administration of these cells with the concomitant administration of RIL 2 can eliminate established pulmonary and hepatic metastases in mice. To characterize the cell that has in vitro LAK activity, we subdivided murine lymphocytes by lysing select subpopulations with the use of complement and antibodies against lymphocyte surface markers or by fluorescence-activated cell sorting. Thy-1.2-negative splenocytes were found to generate near normal amounts of LAK activity after RIL 2 incubation. Small and inconsistent LAK cell activity was generated from Thy-1.2-positive splenocytes. Ia-positive and surface immunoglobulin-positive splenocytes had little or no LAK precursor capability and did not appear to be necessary for LAK activation. Treatment of splenocytes with antiasialo GM1 (anti-ASGM1) heterosera and complement markedly decreased their ability to generate LAK activity. At the effector stage, cytotoxic cells were of the Thy-1.2-positive, Ia-negative phenotype. Ia-depleted cells were separared into subpopulations bearing or not bearing the γFc receptor (γFcR). The majority of cytotoxicity resided in γFcR-positive cells. Thus the precursors of murine LAK cells are 'null' lymphocytes bearing neither T nor B cell surface markers but develop the Thy-1.2 cell surface marker in vitro, in association with the development of lytic activity for fresh tumor cells after stimulation by RIL 2.

Original languageEnglish (US)
Pages (from-to)715-722
Number of pages8
JournalJournal of Immunology
Volume137
Issue number2
StatePublished - 1986
Externally publishedYes

Fingerprint

Lymphokine-Activated Killer Cells
Lymphokines
Interleukin-2
Fc Receptors
Lymphocytes
Null Lymphocytes
B-Cell Antigen Receptors
Intravenous Administration
Neoplasms
Flow Cytometry
B-Lymphocytes
Neoplasm Metastasis
Phenotype

ASJC Scopus subject areas

  • Immunology

Cite this

Murine lymphokine-activated killer (LAK) cells; phenotypic characterization of the precursor and effector cells. / Yang, J. C.; Mule, J. J.; Rosenberg, S. A.

In: Journal of Immunology, Vol. 137, No. 2, 1986, p. 715-722.

Research output: Contribution to journalArticle

Yang, J. C. ; Mule, J. J. ; Rosenberg, S. A. / Murine lymphokine-activated killer (LAK) cells; phenotypic characterization of the precursor and effector cells. In: Journal of Immunology. 1986 ; Vol. 137, No. 2. pp. 715-722.
@article{faaa7c4dc0914aceb2229f6f2c10ab01,
title = "Murine lymphokine-activated killer (LAK) cells; phenotypic characterization of the precursor and effector cells",
abstract = "Murine and human lymphocytes incubated in recombinant interleukin 2 (RIL 2) generate a population of cytotoxic cells (lymphokine-activated killer cells [LAK]), which are able to lyse a wide array of fresh tumor cells but do not lyse fresh normal cells. Intravenous administration of these cells with the concomitant administration of RIL 2 can eliminate established pulmonary and hepatic metastases in mice. To characterize the cell that has in vitro LAK activity, we subdivided murine lymphocytes by lysing select subpopulations with the use of complement and antibodies against lymphocyte surface markers or by fluorescence-activated cell sorting. Thy-1.2-negative splenocytes were found to generate near normal amounts of LAK activity after RIL 2 incubation. Small and inconsistent LAK cell activity was generated from Thy-1.2-positive splenocytes. Ia-positive and surface immunoglobulin-positive splenocytes had little or no LAK precursor capability and did not appear to be necessary for LAK activation. Treatment of splenocytes with antiasialo GM1 (anti-ASGM1) heterosera and complement markedly decreased their ability to generate LAK activity. At the effector stage, cytotoxic cells were of the Thy-1.2-positive, Ia-negative phenotype. Ia-depleted cells were separared into subpopulations bearing or not bearing the γFc receptor (γFcR). The majority of cytotoxicity resided in γFcR-positive cells. Thus the precursors of murine LAK cells are 'null' lymphocytes bearing neither T nor B cell surface markers but develop the Thy-1.2 cell surface marker in vitro, in association with the development of lytic activity for fresh tumor cells after stimulation by RIL 2.",
author = "Yang, {J. C.} and Mule, {J. J.} and Rosenberg, {S. A.}",
year = "1986",
language = "English (US)",
volume = "137",
pages = "715--722",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "2",

}

TY - JOUR

T1 - Murine lymphokine-activated killer (LAK) cells; phenotypic characterization of the precursor and effector cells

AU - Yang, J. C.

AU - Mule, J. J.

AU - Rosenberg, S. A.

PY - 1986

Y1 - 1986

N2 - Murine and human lymphocytes incubated in recombinant interleukin 2 (RIL 2) generate a population of cytotoxic cells (lymphokine-activated killer cells [LAK]), which are able to lyse a wide array of fresh tumor cells but do not lyse fresh normal cells. Intravenous administration of these cells with the concomitant administration of RIL 2 can eliminate established pulmonary and hepatic metastases in mice. To characterize the cell that has in vitro LAK activity, we subdivided murine lymphocytes by lysing select subpopulations with the use of complement and antibodies against lymphocyte surface markers or by fluorescence-activated cell sorting. Thy-1.2-negative splenocytes were found to generate near normal amounts of LAK activity after RIL 2 incubation. Small and inconsistent LAK cell activity was generated from Thy-1.2-positive splenocytes. Ia-positive and surface immunoglobulin-positive splenocytes had little or no LAK precursor capability and did not appear to be necessary for LAK activation. Treatment of splenocytes with antiasialo GM1 (anti-ASGM1) heterosera and complement markedly decreased their ability to generate LAK activity. At the effector stage, cytotoxic cells were of the Thy-1.2-positive, Ia-negative phenotype. Ia-depleted cells were separared into subpopulations bearing or not bearing the γFc receptor (γFcR). The majority of cytotoxicity resided in γFcR-positive cells. Thus the precursors of murine LAK cells are 'null' lymphocytes bearing neither T nor B cell surface markers but develop the Thy-1.2 cell surface marker in vitro, in association with the development of lytic activity for fresh tumor cells after stimulation by RIL 2.

AB - Murine and human lymphocytes incubated in recombinant interleukin 2 (RIL 2) generate a population of cytotoxic cells (lymphokine-activated killer cells [LAK]), which are able to lyse a wide array of fresh tumor cells but do not lyse fresh normal cells. Intravenous administration of these cells with the concomitant administration of RIL 2 can eliminate established pulmonary and hepatic metastases in mice. To characterize the cell that has in vitro LAK activity, we subdivided murine lymphocytes by lysing select subpopulations with the use of complement and antibodies against lymphocyte surface markers or by fluorescence-activated cell sorting. Thy-1.2-negative splenocytes were found to generate near normal amounts of LAK activity after RIL 2 incubation. Small and inconsistent LAK cell activity was generated from Thy-1.2-positive splenocytes. Ia-positive and surface immunoglobulin-positive splenocytes had little or no LAK precursor capability and did not appear to be necessary for LAK activation. Treatment of splenocytes with antiasialo GM1 (anti-ASGM1) heterosera and complement markedly decreased their ability to generate LAK activity. At the effector stage, cytotoxic cells were of the Thy-1.2-positive, Ia-negative phenotype. Ia-depleted cells were separared into subpopulations bearing or not bearing the γFc receptor (γFcR). The majority of cytotoxicity resided in γFcR-positive cells. Thus the precursors of murine LAK cells are 'null' lymphocytes bearing neither T nor B cell surface markers but develop the Thy-1.2 cell surface marker in vitro, in association with the development of lytic activity for fresh tumor cells after stimulation by RIL 2.

UR - http://www.scopus.com/inward/record.url?scp=0022501663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022501663&partnerID=8YFLogxK

M3 - Article

C2 - 2873187

AN - SCOPUS:0022501663

VL - 137

SP - 715

EP - 722

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 2

ER -